Antibody concentrations to Abeta1-42 monomer and soluble oligomers in untreated and antibody-antigen-dissociated intravenous immunoglobulin preparations.

@article{Klaver2010AntibodyCT,
  title={Antibody concentrations to Abeta1-42 monomer and soluble oligomers in untreated and antibody-antigen-dissociated intravenous immunoglobulin preparations.},
  author={Andrea C. Klaver and John M. Finke and Jyothi L. Digambaranath and Mamtha Balasubramaniam and David A. Loeffler},
  journal={International immunopharmacology},
  year={2010},
  volume={10 1},
  pages={115-9}
}
Cognitive improvement in Alzheimer's disease (AD) patients treated with intravenous immunoglobulin (IvIg) has been attributed to its antibodies to amyloid beta (Abeta). We compared the concentrations of specific antibodies to soluble Abeta1-42 conformations, namely Abeta1-42 monomer and Abeta1-42 soluble oligomers, between three IvIg preparations, Gamunex… CONTINUE READING